Monday - April 27, 2026

Category Archives: Business

Graft-versus-host disease Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

DelveInsight Business Research LLP “Graft versus host disease (GVHD) Pipeline Insights, 2021” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Graft versus host disease (GVHD) market. A detailed picture of the Graft … Continue reading →

Overt Hepatic Encephalopathy Epidemiology Forecast Report 2030 | Overt Hepatic Encephalopathy Epidemiology Analysis 2030 | DelveInsight

DelveInsight Business Research LLP DelveInsight’s “Overt Hepatic Encephalopathy – Epidemiology Forecast to 2030” report delivers an in-depth understanding of the disease, historical and forecasted Overt Hepatic Encephalopathy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, … Continue reading →

Irritable Bowel Syndrome Pipeline Drugs & Companies Insight Report, 2021: Analysis of Clinical Trials, Therapies, MOA, Route of Administration, and Developments

DelveInsight Business Research LLP DelveInsight’s, “Irritable Bowel Syndrome (IBS) – Pipeline Insight, 2021,” report provides comprehensive insights about 24+ companies and 24+ pipeline drugs in the Irritable Bowel Syndrome (IBS) pipeline landscape. It covers the pipeline drug profiles, including clinical … Continue reading →

Irritable Bowel Syndrome Epidemiology Forecast Report 2030 | Irritable Bowel Syndrome Epidemiology Analysis 2030 | DelveInsight

DelveInsight Business Research LLP DelveInsight’s ‘Irritable Bowel Syndrome (IBS) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Irritable Bowel Syndrome (IBS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, … Continue reading →

Prurigo Nodularis Pipeline Drugs and Companies Insight Report, 2021: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

DelveInsight Business Research LLP DelveInsight’s, “Prurigo Nodularis – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Prurigo Nodularis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →